How are petitions handled in a supplemental examination proceeding?

MPEP 2813 addresses the handling of petitions in supplemental examination proceedings. According to the guidelines: “37 CFR 1.620(b) provides that the Office may hold in abeyance an action on any petition or other paper filed in a supplemental examination proceeding until after the proceeding is concluded by the electronic issuance of the supplemental examination certificate…

Read More

How is “person” defined in the Hague Agreement for international design applications?

The Hague Agreement provides a specific definition for the term “person” in the context of international design applications. According to MPEP 2904: “Article 1(ix) of the Hague Agreement defines a ‘person’ as a natural person or a legal entity” This definition encompasses: Natural persons (individuals) Legal entities (such as corporations, organizations, or other legally recognized…

Read More

What types of testing are permitted under experimental use in patent law?

The MPEP outlines several types of testing that may be considered permissible experimental use: Developmental testing in the normal context of technological development Experimentation to determine utility under 35 U.S.C. 101 Testing of functional features in design patent applications However, the MPEP explicitly states that market testing is not permitted: “Experimentation to determine product acceptance,…

Read More

What constitutes permitted experimental activity in patent law?

Permitted experimental activity in patent law generally includes testing an invention in the normal context of its technological development. According to MPEP 2133.03(e)(6), “Testing of an invention in the normal context of its technological development is generally within the realm of permitted experimental activity.” This can include: Developmental testing Experimentation to determine utility as applied…

Read More

What is the role of the Patent Trial and Appeal Board in derivation proceedings?

The Patent Trial and Appeal Board (PTAB) plays a crucial role in derivation proceedings. According to MPEP 2310.01, which cites 35 U.S.C. 135(b): “In a derivation proceeding instituted under subsection (a), the Patent Trial and Appeal Board shall determine whether an inventor named in the earlier application derived the claimed invention from an inventor named…

Read More

What are the limitations on amendments after the second Office action in patent reexamination?

After the second Office action in patent reexamination, which is typically final, there are limitations on amendments. MPEP 2269 states: “Any amendment after the second Office action, which will normally be final as provided for in MPEP § 2271, must ordinarily be restricted to the rejection or to the objection or requirement made.” This means…

Read More